TABLE 2

Results of 33 Evaluable ¹⁸F-FDOPA PET and ¹¹¹In-Pentetreotide SRS Examinations on Per-Patient Basis and FDOPA/SRS Comparison

Examination	PET system	Tumor site and type: final diagnosis	Reference	FDOPA PET	SRS	Comparison: FDOPA/SRS	Tumor site
1 (patient 1)	PET	Small bowel carcinoid	Histology	TP	TP	FDOPA > SRS	Liver^†
2 (patient 2)^*	PET	Small bowel carcinoid	Histology	TP	TP	FDOPA = SRS	LNP^‡
3 (patient 2)^*	PET/CT	Small bowel carcinoid	Histology	FP	FN	FDOPA = SRS	LNP^§
4 (patient 3)	PET/CT	Small bowel carcinoid	Follow-up	TP	TP	FDOPA = SRS	Liver^‡, LNP^‡, thorax^‡
5 (patient 4)	PET	Small bowel carcinoid	Follow-up	TN	FP	FDOPA > SRS	—
6 (patient 5)	PET/CT	Small bowel carcinoid	Histology	FN	FN	FDOPA = SRS	Small bowel (primary)^§
7 (patient 6)	PET	Small bowel carcinoid	Histology	TP	TP	FDOPA = SRS	LNP^‡
8 (patient 7)	PET	Small bowel carcinoid	Histology	TP	TP	FDOPA > SRS	Liver^†
9 (patient 8)^*	PET	Small bowel carcinoid	Histology	TP	TP	FDOPA > SRS	Liver^†, LNP^†
10 (patient 8)^*	PET	Small bowel carcinoid	Follow-up	TP	TP	FDOPA > SRS	Liver^†, LNP^†, bone^‡
11 (patient 9)	PET	Small bowel carcinoid	Follow-up	TN	TN	FDOPA = SRS	—
12 (patient 10)	PET	Small bowel carcinoid	Follow-up	TP	TP	FDOPA > SRS	Liver^†, LNP^†
13 (patient 11)	PET	Small bowel carcinoid	Follow-up	TP	TP	FDOPA > SRS	LNP^†
14 (patient 12)	PET	Small bowel carcinoid	Histology	TP	TP	FDOPA = SRS	Bone^‡
15 (patient 13)	PET	Small bowel carcinoid	Histology	TP	FN	FDOPA > SRS	Liver^‖, LNP^‖
16 (patient 14)	PET	Small bowel carcinoid	Follow-up	TP	TP	FDOPA > SRS	Liver^†, LNP^†
17 (patient 15)	PET	Small bowel carcinoid	Follow-up	TN	TN	FDOPA = SRS	—
18 (patient 16)	PET/CT	Small bowel carcinoid	Histology	TP	TP	FDOPA > SRS	Small bowel (primary)^†
19 (patient 17)	PET	Carcinoid	Follow-up	TP	TP	FDOPA = SRS	Liver^‡, primary^§
20 (patient 18)	PET/CT	Pancreas	Histology	FN	TP	FDOPA < SRS	Pancreas (primary)^¶
21 (patient 19)	PET/CT	Pancreas	Follow-up	FN	FN	FDOPA = SRS	Pancreas (primary)^§
22 (patient 20)	PET/CT	Pancreas	Histology	FN	FN	FDOPA = SRS	Pancreas (primary)^§
23 (patient 21)	PET	Pancreas	Histology	TP	TP	FDOPA = SRS	Liver^‡, LNP^‡, pancreas (primary)^§
24 (patient 22)	PET	Stomach	Histology	FN	TP	FDOPA < SRS	Liver^¶, LNP^¶, bone^¶, stomach (primary)^§
25 (patient 23)	PET	Stomach	Histology	FN	FN	FDOPA = SRS	Stomach (primary)^§
26 (patient 24)	PET	Duodenum	Follow-up	FN	TP	FDOPA < SRS	LNP^#
27 (patient 25)	PET	Duodenum	Histology	TP	TP	FDOPA < SRS	Liver^#
28 (patient 26)	PET	Pancreas	Histology	FN	TP	FDOPA < SRS	Pancreas (primary)^§, liver^¶
29 (patient 27)	PET/CT	Pancreas	Histology	TP	TP	FDOPA = SRS	Pancreas (primary)^‡, liver^‡, LNP^‡
30 (patient 28)	PET	Pancreas	Histology	FN	TP	FDOPA < SRS	LNP^¶
31 (patient 29)^*	PET	Pancreas	Follow-up	TN	TN	FDOPA = SRS	—
32 (patient 29)^*	PET	Pancreas	Follow-up	TN	FP	FDOPA > SRS	—
33 (patient 30)	PET	Pancreas	Histology	FN	TP	FDOPA < SRS	Pancreas (recurrence)^¶

↵* Two examinations performed on patients 2, 8, and 29.
↵† FDOPA + > SRS +.
↵‡ FDOPA + = SRS +.
↵§ FDOPA − and SRS −.
↵‖ FDOPA + and SRS −.
↵¶ FDOPA − and SRS +.
↵# FDOPA + < SRS +.
TP = true-positive; LNP = abdominal lymph nodes or peritoneal lesions; FP = false-positive; FN = false-negative; TN = true-negative.